Sign In
Buy TEVA
$34.43
-0.0300 (-0.0871%)
At Close: Aug 04, 2026
2 Biotech Stocks That Could Soar in the Third Quarter
09:41am, Saturday, 02'nd Jul 2022 The Motley Fool
Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.
Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022
04:09pm, Wednesday, 29'th Jun 2022
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2022 financial results on Wednesda
2 Buffett Stocks That Outperformed the S&P During the Great Recession
02:37pm, Tuesday, 28'th Jun 2022 The Motley Fool
Are these stocks still good buys today?
2 Buffett Stocks That Outperformed the S&P During the Great Recession
10:37am, Tuesday, 28'th Jun 2022
Are these stocks still good buys today?
AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention
02:32pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
With the latest approval for chronic migraine prevention, AbbVie's(ABBV) Qulipta becomes the only CGRP receptor antagonist approved for a broad preventive treatment of migraine indication.
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week
09:54pm, Sunday, 19'th Jun 2022
The Health Care sector has been relatively strong this year amid stock market volatility. Teva Pharmaceuticals struggles with opioid lawsuits, generic drug issues as shares drift lower.
Nasdaq Bear Market: 3 of the Cheapest Stocks You Can Confidently Buy Right Now
09:21am, Wednesday, 15'th Jun 2022 The Motley Fool
These highly profitable stocks are valued at just three to six times Wall Street's forecast earnings for 2023.
Nasdaq Bear Market: 3 of the Cheapest Stocks You Can Confidently Buy Right Now
05:21am, Wednesday, 15'th Jun 2022
These highly profitable stocks are valued at just three to six times Wall Street's forecast earnings for 2023.
Why Is Bausch (BHC) Down 11.2% Since Last Earnings Report?
03:30pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's A Better Pick Over Abbott Stock
07:15am, Tuesday, 31'st May 2022
If we look at stock returns, Abbott's -1% return is better than Teva's -13% change over the last twelve months.
Teva, Allergan reach $161.5 million opioid settlement with West Virginia
10:03am, Wednesday, 25'th May 2022
(Reuters) -Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorne
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
04:08pm, Tuesday, 17'th May 2022 Benzinga
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.
The Teva P
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
02:21pm, Tuesday, 17'th May 2022 Benzinga
Upgrades
Tudor Pickering upgraded the previous rating for Tesla Inc (NASDAQ:TSLA) from Sell to Hold. In the first quarter, Tesla showed an EPS of $3.22, compared to $0.93 from the year-ago quarter. A
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
01:57pm, Tuesday, 17'th May 2022
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced new study findings based on newly established clinical thresholds on short-acting beta-agonist (SABA) use and real-world usage of ProAir Di
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
12:21pm, Tuesday, 17'th May 2022
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA) stock, according to BofA Securities.
